ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 52 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $400,943 | +23.2% | 153,618 | +69.0% | 0.00% | – |
| Q2 2023 | $325,476 | +47.9% | 90,915 | -9.9% | 0.00% | – |
| Q1 2023 | $220,080 | +10.8% | 100,954 | +511.6% | 0.00% | – |
| Q4 2022 | $198,579 | +55837.7% | 16,507 | -69.9% | 0.00% | – |
| Q3 2022 | $355 | +173.1% | 54,902 | +93.6% | 0.00% | – |
| Q2 2022 | $130 | -100.0% | 28,363 | -59.6% | 0.00% | – |
| Q1 2022 | $607,000 | -63.7% | 70,183 | -40.0% | 0.00% | – |
| Q4 2021 | $1,672,000 | +284.4% | 117,034 | +492.0% | 0.00% | – |
| Q3 2021 | $435,000 | -7.2% | 19,768 | -43.6% | 0.00% | – |
| Q2 2021 | $469,000 | +133.3% | 35,055 | +77.4% | 0.00% | – |
| Q1 2021 | $201,000 | – | 19,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 801,242 | $3,876,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 624,000 | $3,039,000 | 0.18% |
| Rossmore Private Capital | 15,061 | $73,000 | 0.03% |
| Sterling Investment Advisors, Ltd. | 3,150 | $15,000 | 0.01% |
| Squarepoint Ops LLC | 14,500 | $71,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 500 | $2,000 | 0.00% |
| Close Asset Management Ltd | 2,000 | $10,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 16,900 | $82,000 | 0.00% |
| SIMPLEX TRADING, LLC | 547 | $2,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 861 | $4,000 | 0.00% |